Biomm S.A - Asset Resilience Ratio

Latest as of September 2025: 14.65%

Biomm S.A (BIOM3) has an Asset Resilience Ratio of 14.65% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BIOM3 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

R$71.03 Million

≈ $13.94 Million USD Cash + Short-term Investments

Total Assets

R$485.03 Million

≈ $95.17 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Biomm S.A's Asset Resilience Ratio has changed over time. See BIOM3 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Biomm S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Biomm S.A worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	R$11.50 Million	2.37%
Short-term Investments	R$59.53 Million	12.27%
Total Liquid Assets	R$71.03 Million	14.65%

Asset Resilience Insights

Moderate Liquidity: Biomm S.A has 14.65% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Biomm S.A Industry Peers by Asset Resilience Ratio

Compare Biomm S.A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Biomm S.A (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Biomm S.A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.70%	R$138.28 Million ≈ $27.13 Million	R$465.66 Million ≈ $91.37 Million	+14.47pp
2023-12-31	15.22%	R$52.47 Million ≈ $10.29 Million	R$344.70 Million ≈ $67.64 Million	-9.16pp
2022-12-31	24.38%	R$98.78 Million ≈ $19.38 Million	R$405.09 Million ≈ $79.49 Million	+9.69pp
2021-12-31	14.69%	R$54.34 Million ≈ $10.66 Million	R$369.83 Million ≈ $72.57 Million	-10.23pp
2020-12-31	24.93%	R$108.43 Million ≈ $21.28 Million	R$434.97 Million ≈ $85.35 Million	-1.88pp
2019-12-31	26.80%	R$104.21 Million ≈ $20.45 Million	R$388.77 Million ≈ $76.28 Million	+2.25pp
2018-12-31	24.55%	R$75.06 Million ≈ $14.73 Million	R$305.68 Million ≈ $59.98 Million	+11.50pp
2017-12-31	13.06%	R$34.26 Million ≈ $6.72 Million	R$262.39 Million ≈ $51.49 Million	-3.19pp
2016-12-31	16.25%	R$38.57 Million ≈ $7.57 Million	R$237.38 Million ≈ $46.58 Million	-22.95pp
2015-12-31	39.20%	R$90.03 Million ≈ $17.67 Million	R$229.67 Million ≈ $45.07 Million	-17.51pp
2014-12-31	56.71%	R$101.83 Million ≈ $19.98 Million	R$179.56 Million ≈ $35.23 Million	+4.71pp
2013-12-31	52.00%	R$71.80 Million ≈ $14.09 Million	R$138.08 Million ≈ $27.09 Million	--

pp = percentage points

About Biomm S.A

SA:BIOM3 Brazil Biotechnology

Market Cap

$201.38 Million

R$1.03 Billion BRL

Market Cap Rank

#16508 Global

#162 in Brazil

Share Price

R$7.50

Change (1 day)

+2.04%

52-Week Range

R$5.90 - R$10.64

All Time High

R$23.65